Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444418 · ClinicalTrials.gov registry record · Phase 3
Medication and Counseling for Controlled Drinking (Project SMART)
A Phase 3 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00444418: Completed Phase 3 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
NCT00444418 is a Phase 3 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 200 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00444418, a Phase 3 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effectiveness of medication and specialized psychotherapy in helping gay and bisexual men who do not want to quit drinking learn how to reduce their drinking to healthier levels. More information on the study is available at www.projectsmartnyc.org.
Interventions
- DRUG Naltrexone
- BEHAVIORAL Modified Behavioral Self-Control Psychotherapy
- BEHAVIORAL Brief Behavioral Compliance Enhancement Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
What the finished NCT00444418 record still lists
NCT00444418 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Naltrexone is the first listed.
NCT00444418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00444418 about?
NCT00444418 is a clinical study titled "Medication and Counseling for Controlled Drinking (Project SMART)". The purpose of this study is to study the effectiveness of medication and specialized psychotherapy in helping gay and bisexual men who do not want to quit drinking learn how to reduce their drinking to healthier levels. More information on the study is available at www.projectsmartnyc.org.
What is the current status of trial NCT00444418?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2006-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00444418?
The interventions under investigation include: Naltrexone (DRUG), Modified Behavioral Self-Control Psychotherapy (BEHAVIORAL), Brief Behavioral Compliance Enhancement Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00444418?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00444418's enrollment target sits among peer trials
200 1353rd of 2000 higher than 613 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia